REVBW Company Profile and Key Details

NASDAQ : REVBW

Revelation Biosciences

$0.01

-0.0015-15.96%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Revelation Biosciences, Inc. (REVBW) stock declined over -15.96%, trading at $0.01 on NASDAQ, down from the previous close of $0.01. The stock opened at $0.01, fluctuating between $0.01 and $0.01 in the recent session.

Stock Snapshot

0.0094

Prev. Close

46.8K

Market Cap

0.0079

Day Low

N/A

P/E Ratio

-18.45

EPS (TTM)

-27.54

Cash Flow per Share

0.01

Open

5.92M

Number of Shares

0.0079

Day High

99.34%

Free Float in %

25.13

Book Value

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 10, 2026	0.01	0.01	0.01	0.01	10
Sep 08, 2026	0.01	0.01	0.01	0.01	28.43K
Sep 04, 2026	0.01	0.01	0.01	0.01	50
Aug 24, 2026	0.01	0.01	0.01	0.01	249
Aug 21, 2026	0.01	0.01	0.01	0.01	20.74K
Aug 20, 2026	0.01	0.01	0.01	0.01	426
Aug 18, 2026	0.01	0.01	0.01	0.01	50
Aug 17, 2026	0.01	0.01	0.01	0.01	553
Aug 14, 2026	0.01	0.01	0.01	0.01	1K
Aug 13, 2026	0.01	0.01	0.01	0.01	36
Aug 11, 2026	0.01	0.01	0.01	0.01	1.9K
Aug 07, 2026	0.01	0.01	0.01	0.01	4
Jul 30, 2026	0.01	0.01	0.01	0.01	100
Jul 29, 2026	0.01	0.01	0.01	0.01	5.2K
Jul 27, 2026	0.01	0.01	0.01	0.01	0
Jul 24, 2026	0.01	0.01	0.01	0.01	141
Jul 23, 2026	0.01	0.01	0.01	0.01	100
Jul 22, 2026	0.01	0.01	0.01	0.01	2
Jul 21, 2026	0.01	0.01	0.01	0.01	32.94K
Jul 20, 2026	0.01	0.01	0.01	0.01	131

Contact Details

San Diego, CA 92122

United States

https://www.revbiosciences.com 917 622 5800

About Company

Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering immunology-based therapies and diagnostic tools aimed at preventing and treating a range of illnesses. Their flagship therapeutic, REVTx-99, is an intranasal immunomodulator designed to both prevent and treat a broad spectrum of respiratory viral infections, including SARS-CoV-2 (and its variants), influenza A and B, parainfluenza, rhinovirus, and RSV. Furthermore, its potential extends to addressing allergic rhinitis and chronic nasal congestion. The company's pipeline also includes REVTx-200, an intranasal immunomodulator intended as an adjunct to enhance the efficacy of intramuscular vaccinations, thereby boosting immunity. Additionally, they are developing REVDx-501, a rapid diagnostic test designed for convenient home use to detect respiratory viral infections. Established in 2019, the company is headquartered in New York, New York.

Stock Peers

ARGX

-18.27-1.82%

argenx SE$984.04 REGN

-14.39-1.78%

Regeneron Pharmaceuticals, Inc.$793.26 MDGL

-13.54-2.48%

Madrigal Pharmaceuticals, Inc.$533.12 VRTX

-6.56-1.26%

Vertex Pharmaceuticals Incorporated$514.56 UTHR

-2.96-0.58%

United Therapeutics Corporation$503.86 KRYS

-2.54-0.73%

Krystal Biotech, Inc.$345.55 ONC

-9.2-2.62%

BeOne Medicines AG$341.80 PRAX

-6.73-1.95%

Praxis Precision Medicines, Inc.$338.57 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

1.2+0.42%

Ligand Pharmaceuticals Incorporated$289.25

Earnings & Analyst Outlook

Revelation Biosciences, Inc. earnings surprise history is a mixed track record. The quarter that ended August 06, 2026, missed forecasts by -0.57%. The prior quarter beat by 27.23%. Over the last six quarters, Apple has recorded several small beats. These include 10.34% in August 08, 2025.

Frequently Asked Questions

What is the current Revelation Biosciences, Inc. (REVBW) stock price?

Revelation Biosciences, Inc. (NASDAQ: REVBW) stock price is $0.01 in the last trading session. During the trading session, REVBW stock reached the peak price of $0.01 while $0.01 was the lowest point it dropped to. The percentage change in REVBW stock occurred in the recent session was -15.96% while the dollar amount for the price change in REVBW stock was - $0.00.

REVBW's industry and sector of operation?

The NASDAQ listed REVBW is part of Biotechnology industry that operates in the broader Healthcare sector. Revelation Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of REVBW?

No Data

How REVBW did perform over past 52-week?

REVBW's closing price is 0% higher than its 52-week low of $0.01 where as its distance from 52-week high of $0.01 is -36.8%.

How many employees does REVBW have?

Number of REVBW employees currently stands at 8.

Link for REVBW official website?

Official Website of REVBW is: https://www.revbiosciences.com

How do I contact REVBW?

REVBW could be contacted at phone 917 622 5800 and can also be accessed through its website. REVBW operates from 4660 La Jolla Village Drive, San Diego, CA 92122, United States.

How many shares of REVBW are traded daily?

REVBW stock volume for the day was 10 shares. The average number of REVBW shares traded daily for last 3 months was 44.65K.

What is the market cap of REVBW currently?

The market value of REVBW currently stands at $46.80K with its latest stock price at $0.01 and 5.92M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Price Chart

Stock Price Today

Stock Snapshot

0.0094

Prev. Close

46.8K

Market Cap

0.0079

Day Low

N/A

P/E Ratio

-18.45

EPS (TTM)

-27.54

Cash Flow per Share

0.01

Open

5.92M

Number of Shares

0.0079

Day High

99.34%

Free Float in %

25.13

Book Value

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 10, 2026	0.01	0.01	0.01	0.01	10
Sep 08, 2026	0.01	0.01	0.01	0.01	28.43K
Sep 04, 2026	0.01	0.01	0.01	0.01	50
Aug 24, 2026	0.01	0.01	0.01	0.01	249
Aug 21, 2026	0.01	0.01	0.01	0.01	20.74K
Aug 20, 2026	0.01	0.01	0.01	0.01	426
Aug 18, 2026	0.01	0.01	0.01	0.01	50
Aug 17, 2026	0.01	0.01	0.01	0.01	553
Aug 14, 2026	0.01	0.01	0.01	0.01	1K
Aug 13, 2026	0.01	0.01	0.01	0.01	36
Aug 11, 2026	0.01	0.01	0.01	0.01	1.9K
Aug 07, 2026	0.01	0.01	0.01	0.01	4
Jul 30, 2026	0.01	0.01	0.01	0.01	100
Jul 29, 2026	0.01	0.01	0.01	0.01	5.2K
Jul 27, 2026	0.01	0.01	0.01	0.01	0
Jul 24, 2026	0.01	0.01	0.01	0.01	141
Jul 23, 2026	0.01	0.01	0.01	0.01	100
Jul 22, 2026	0.01	0.01	0.01	0.01	2
Jul 21, 2026	0.01	0.01	0.01	0.01	32.94K
Jul 20, 2026	0.01	0.01	0.01	0.01	131

Contact Details

San Diego, CA 92122

United States

https://www.revbiosciences.com 917 622 5800

About Company

Stock Peers

ARGX

-18.27-1.82%

argenx SE$984.04 REGN

-14.39-1.78%

Regeneron Pharmaceuticals, Inc.$793.26 MDGL

-13.54-2.48%

Madrigal Pharmaceuticals, Inc.$533.12 VRTX

-6.56-1.26%

Vertex Pharmaceuticals Incorporated$514.56 UTHR

-2.96-0.58%

United Therapeutics Corporation$503.86 KRYS

-2.54-0.73%

Krystal Biotech, Inc.$345.55 ONC

-9.2-2.62%

BeOne Medicines AG$341.80 PRAX

-6.73-1.95%

Praxis Precision Medicines, Inc.$338.57 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

1.2+0.42%

Ligand Pharmaceuticals Incorporated$289.25

Company Overview

The stock is currently trading near its 52-week low $0.01 and $0.01. With a market capitalization of about $46.80 thousand, Revelation Biosciences, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.12). Key stats such as the average daily volume over the past year has been around 44.65 thousand shares, volume is running light vs its 52-week average. Headquartered in San Diego, CA, Revelation Biosciences, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO James Rolke, the company employs approximately 8 people and listed since January 11, 2022. Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering immunology-based therapies and diagnostic tools aimed at preventing and treating a range of illnesses.

Technical Performance

REVBW has shown weak momentum, losing -28.14% over the past week and -39.52% over the past quarter, though year-to-date performance is down -39.52%. Average 10-day trading volume of 9.50 thousand shares is below the 3-month average of 12.54 thousand, indicating normal recent market interest.

Valuation Metrics

Revelation Biosciences, Inc. trades at a P/E ratio of -0.14, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 0.38 suggesting the stock is closer to book value. The P/FCF stands at -0.42, also above market averages.

Dividend & Fair Value

Revelation Biosciences, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.60. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Financial & Profitability Overview

Over the trailing twelve months, Revelation Biosciences has not generated any revenue. Returns are negative, with ROA at -0.98% and ROE at -1.81%.
On valuation metrics, Revelation Biosciences trades at a P/E of -0.14, P/S of 0.00 and P/B of 0.38. The current ratio is 6.21 and quick ratio is 6.21. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -17146.77 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 0.07, supported by a cash flow-to-debt ratio of -12.61.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Revelation Biosciences posted revenue of $0.00, down slightly from $0.00 in the prior quarter. Gross profit was - $25.05K (margin 0.00%). Operating income was - $8.66M (margin 0.0%). Net income was- $120.25K (EPS - $0.53).
The company ended the quarter with $11.99M in cash and short-term investments, a total debt of $0.00, and net debt of - $11.99M. Total assets were $12.21M, with equity of $6.65M. Financials further reflected weakness, with operating cash flow of - $7.29M, free cash flow of - $7.29M, and capital expenditures of $0.00.

Price Forecast & Outlook

Our AI price prediction model suggests that Revelation Biosciences, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 26.58%, with price expected at $0.01 by November 24, 2023, within a range of $0.01 to $0.01

Key Takeaways

Revelation Biosciences, Inc. (NASDAQ:REVBW) shares are down -39.52% year-to-date Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Revelation Biosciences, Inc. trading at a premium to the broader market with a P/E of -0.14.

Frequently Asked Questions

What is the current Revelation Biosciences, Inc. (REVBW) stock price?

REVBW's industry and sector of operation?

Who are the executives of REVBW?

No Data

How REVBW did perform over past 52-week?

REVBW's closing price is 0% higher than its 52-week low of $0.01 where as its distance from 52-week high of $0.01 is -36.8%.

How many employees does REVBW have?

Number of REVBW employees currently stands at 8.

Link for REVBW official website?

Official Website of REVBW is: https://www.revbiosciences.com

How do I contact REVBW?

REVBW could be contacted at phone 917 622 5800 and can also be accessed through its website. REVBW operates from 4660 La Jolla Village Drive, San Diego, CA 92122, United States.

How many shares of REVBW are traded daily?

REVBW stock volume for the day was 10 shares. The average number of REVBW shares traded daily for last 3 months was 44.65K.

What is the market cap of REVBW currently?

The market value of REVBW currently stands at $46.80K with its latest stock price at $0.01 and 5.92M of its shares outstanding.

Employees	8
Beta	-0.12
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	8
Beta	-0.12
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

REVBW Company Profile and Key Details

Revelation Biosciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Earnings & Analyst Outlook

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Financial & Profitability Overview

Quarterly Financial Highlights

Technical Performance

Dividend & Fair Value

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics